Ensign Peak Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
ICM
Ensign Peak Advisors's CNMD Position: Q2 2026 in Review
Ensign Peak Advisors held its CONMED (CNMD) position steady in Q2 2026 at 2,040 shares worth $66.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.
Ensign Peak Advisors first reported a position in CNMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.25M in Q2 2021. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Ensign Peak Advisors held 2,040 shares of CONMED worth $66.8K as of Q2 2026.
- Ensign Peak Advisors left its CONMED share count unchanged in Q2 2026.
- CONMED made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1687 holding.
- Ensign Peak Advisors first reported a position in CONMED in Q4 2019 and has held it in 27 quarters since.
- Ensign Peak Advisors's CONMED position peaked at $3.25M in Q2 2021.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.